1-2 of 2
Kathleen Stefunek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy

Jason Valent, John Silowsky, Michael R. Kurman, Eileen Daniel, Janet Jobes, Mark Harnett, Sherry Fada, Michael Spector, Kathleen Stefunek, Heather Staley, Kristen Schlueter, Christy J. Samaras, Faiz Anwer, Jack Khouri, Jeffrey A. Zonder, Michaela Liedtke, Susan B. Sobolov
Journal: Blood
Blood (2021) 138 (Supplement 1): 2724.
https://doi.org/10.1182/blood-2021-148905
Published: 2021
Journal Articles

Safety, Tolerability and Efficacy of Cael-101 in AL Amyloidosis Patients Treated on a Phase 2, Open-Label, Dose Selection Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis

Jack Khouri, MD, Faiz Anwer, MD, Christy J. Samaras, DO, Alex V. Mejia Garcia, MD, Omer N. Koc, MD, Beth M. Faiman, PhDCNP, Kimberly Hamilton, CNP, Saveta Mathur, CNP, Cynthia Scott, CNP, Kathleen Stefunek, RN, Josephine Sgobbo, RN, Sherry Fada, Brittany Lewis, Kelly Shepherd, Naqib Ahmad, Madeleine Knebusch, Susan B. Sobolov, PhD, Janet Jobes, Eileen Daniel, Michael Spector, BS, Jason Valent, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-137235
Published: 2020